US Stock MarketDetailed Quotes

LYEL Lyell Immunopharma

Watchlist
  • 0.674
  • -0.086-11.37%
Close Dec 13 16:00 ET
  • 0.700
  • +0.026+3.86%
Post 20:01 ET
196.86MMarket Cap-0.85P/E (TTM)

Lyell Immunopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
36.00%34K
-51.85%13K
-95.38%3K
-99.85%130K
-99.97%13K
733.33%25K
-99.92%27K
-88.25%65K
695.15%84.68M
1,614.60%48.39M
Operating revenue
36.00%34K
-51.85%13K
-95.38%3K
-99.85%130K
-99.97%13K
733.33%25K
-99.92%27K
-88.25%65K
695.15%84.68M
1,614.60%48.39M
Cost of revenue
Gross profit
Operating expense
-14.43%50.54M
-21.83%51.54M
-11.25%55.58M
-9.05%247.14M
-5.78%59.52M
-11.10%59.06M
-9.68%65.93M
-9.41%62.62M
20.55%271.74M
25.44%63.17M
Selling and administrative expenses
-24.11%11.77M
-35.60%12.26M
-30.01%13.49M
-42.90%66.98M
-50.03%13.17M
-40.55%15.51M
-37.51%19.03M
-43.99%19.28M
31.72%117.31M
-17.33%26.35M
-General and administrative expense
-24.11%11.77M
-35.60%12.26M
-30.01%13.49M
-42.90%66.98M
-50.03%13.17M
-40.55%15.51M
-37.51%19.03M
-43.99%19.28M
31.72%117.31M
-17.33%26.35M
Research and development costs
-9.92%39.5M
-15.19%40.26M
-3.26%43.17M
14.92%182.95M
23.57%47M
5.39%43.85M
8.58%47.47M
24.56%44.63M
14.78%159.19M
97.21%38.03M
Other operating expenses
-150.00%-730K
-71.53%-976K
15.37%-1.09M
41.31%-2.79M
47.02%-641K
76.66%-292K
51.41%-569K
-14.80%-1.29M
-104.56%-4.75M
-51.63%-1.21M
Operating profit
14.45%-50.51M
21.81%-51.53M
11.16%-55.58M
-32.05%-247.01M
-302.52%-59.51M
11.14%-59.04M
-76.87%-65.91M
8.78%-62.56M
12.91%-187.06M
68.90%-14.78M
Net non-operating interest income expense
-9.73%5.97M
20.90%6.36M
51.63%6.82M
232.53%23.45M
105.15%7.08M
193.56%6.61M
452.94%5.26M
1,032.75%4.5M
505.41%7.05M
969.04%3.45M
Non-operating interest income
-9.73%5.97M
20.90%6.36M
51.63%6.82M
232.53%23.45M
105.15%7.08M
193.56%6.61M
452.94%5.26M
1,032.75%4.5M
505.41%7.05M
969.04%3.45M
Other net income (expense)
-102.72%-43K
80.15%-645K
-33.83%-11.91M
-255.83%-11.08M
-117.25%-506K
126.01%1.58M
-23,107.14%-3.25M
-25,528.57%-8.9M
91.50%-3.11M
108.04%2.93M
Special income (charges)
--0
--0
-30.01%-13M
-158.46%-12.92M
--0
--0
---2.92M
---10M
86.28%-5M
--0
-Write off
--0
--0
30.01%13M
158.46%12.92M
--0
--0
--2.92M
--10M
-86.28%5M
--0
Other non- operating income (expenses)
-102.72%-43K
-97.85%-645K
-0.91%1.09M
-2.17%1.85M
-117.25%-506K
247.75%1.58M
-2,228.57%-326K
3,042.86%1.1M
1,272.05%1.89M
6,768.18%2.93M
Income before tax
12.33%-44.58M
28.30%-45.81M
9.40%-60.67M
-28.13%-234.63M
-530.34%-52.93M
27.62%-50.85M
-75.89%-63.89M
1.74%-66.96M
26.82%-183.12M
89.97%-8.4M
Income tax
Net income
12.33%-44.58M
28.30%-45.81M
9.40%-60.67M
-28.13%-234.63M
-530.34%-52.93M
27.62%-50.85M
-75.89%-63.89M
1.74%-66.96M
26.82%-183.12M
89.97%-8.4M
Net income continuous Operations
12.33%-44.58M
28.30%-45.81M
9.40%-60.67M
-28.13%-234.63M
-530.34%-52.93M
27.62%-50.85M
-75.89%-63.89M
1.74%-66.96M
26.82%-183.12M
89.97%-8.4M
Minority interest income
Net income attributable to the parent company
12.33%-44.58M
28.30%-45.81M
9.40%-60.67M
-28.13%-234.63M
-530.34%-52.93M
27.62%-50.85M
-75.89%-63.89M
1.74%-66.96M
26.82%-183.12M
89.97%-8.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
12.33%-44.58M
28.30%-45.81M
9.40%-60.67M
-28.13%-234.63M
-530.34%-52.93M
27.62%-50.85M
-75.89%-63.89M
1.74%-66.96M
26.82%-183.12M
89.97%-8.4M
Basic earnings per share
15.00%-0.17
30.77%-0.18
11.11%-0.24
-25.68%-0.93
-566.67%-0.2
28.57%-0.2
-73.33%-0.26
3.57%-0.27
59.78%-0.74
91.30%-0.03
Diluted earnings per share
15.00%-0.17
30.77%-0.18
11.11%-0.24
-25.68%-0.93
-566.67%-0.2
28.57%-0.2
-73.33%-0.26
3.57%-0.27
59.78%-0.74
91.30%-0.03
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 36.00%34K-51.85%13K-95.38%3K-99.85%130K-99.97%13K733.33%25K-99.92%27K-88.25%65K695.15%84.68M1,614.60%48.39M
Operating revenue 36.00%34K-51.85%13K-95.38%3K-99.85%130K-99.97%13K733.33%25K-99.92%27K-88.25%65K695.15%84.68M1,614.60%48.39M
Cost of revenue
Gross profit
Operating expense -14.43%50.54M-21.83%51.54M-11.25%55.58M-9.05%247.14M-5.78%59.52M-11.10%59.06M-9.68%65.93M-9.41%62.62M20.55%271.74M25.44%63.17M
Selling and administrative expenses -24.11%11.77M-35.60%12.26M-30.01%13.49M-42.90%66.98M-50.03%13.17M-40.55%15.51M-37.51%19.03M-43.99%19.28M31.72%117.31M-17.33%26.35M
-General and administrative expense -24.11%11.77M-35.60%12.26M-30.01%13.49M-42.90%66.98M-50.03%13.17M-40.55%15.51M-37.51%19.03M-43.99%19.28M31.72%117.31M-17.33%26.35M
Research and development costs -9.92%39.5M-15.19%40.26M-3.26%43.17M14.92%182.95M23.57%47M5.39%43.85M8.58%47.47M24.56%44.63M14.78%159.19M97.21%38.03M
Other operating expenses -150.00%-730K-71.53%-976K15.37%-1.09M41.31%-2.79M47.02%-641K76.66%-292K51.41%-569K-14.80%-1.29M-104.56%-4.75M-51.63%-1.21M
Operating profit 14.45%-50.51M21.81%-51.53M11.16%-55.58M-32.05%-247.01M-302.52%-59.51M11.14%-59.04M-76.87%-65.91M8.78%-62.56M12.91%-187.06M68.90%-14.78M
Net non-operating interest income expense -9.73%5.97M20.90%6.36M51.63%6.82M232.53%23.45M105.15%7.08M193.56%6.61M452.94%5.26M1,032.75%4.5M505.41%7.05M969.04%3.45M
Non-operating interest income -9.73%5.97M20.90%6.36M51.63%6.82M232.53%23.45M105.15%7.08M193.56%6.61M452.94%5.26M1,032.75%4.5M505.41%7.05M969.04%3.45M
Other net income (expense) -102.72%-43K80.15%-645K-33.83%-11.91M-255.83%-11.08M-117.25%-506K126.01%1.58M-23,107.14%-3.25M-25,528.57%-8.9M91.50%-3.11M108.04%2.93M
Special income (charges) --0--0-30.01%-13M-158.46%-12.92M--0--0---2.92M---10M86.28%-5M--0
-Write off --0--030.01%13M158.46%12.92M--0--0--2.92M--10M-86.28%5M--0
Other non- operating income (expenses) -102.72%-43K-97.85%-645K-0.91%1.09M-2.17%1.85M-117.25%-506K247.75%1.58M-2,228.57%-326K3,042.86%1.1M1,272.05%1.89M6,768.18%2.93M
Income before tax 12.33%-44.58M28.30%-45.81M9.40%-60.67M-28.13%-234.63M-530.34%-52.93M27.62%-50.85M-75.89%-63.89M1.74%-66.96M26.82%-183.12M89.97%-8.4M
Income tax
Net income 12.33%-44.58M28.30%-45.81M9.40%-60.67M-28.13%-234.63M-530.34%-52.93M27.62%-50.85M-75.89%-63.89M1.74%-66.96M26.82%-183.12M89.97%-8.4M
Net income continuous Operations 12.33%-44.58M28.30%-45.81M9.40%-60.67M-28.13%-234.63M-530.34%-52.93M27.62%-50.85M-75.89%-63.89M1.74%-66.96M26.82%-183.12M89.97%-8.4M
Minority interest income
Net income attributable to the parent company 12.33%-44.58M28.30%-45.81M9.40%-60.67M-28.13%-234.63M-530.34%-52.93M27.62%-50.85M-75.89%-63.89M1.74%-66.96M26.82%-183.12M89.97%-8.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 12.33%-44.58M28.30%-45.81M9.40%-60.67M-28.13%-234.63M-530.34%-52.93M27.62%-50.85M-75.89%-63.89M1.74%-66.96M26.82%-183.12M89.97%-8.4M
Basic earnings per share 15.00%-0.1730.77%-0.1811.11%-0.24-25.68%-0.93-566.67%-0.228.57%-0.2-73.33%-0.263.57%-0.2759.78%-0.7491.30%-0.03
Diluted earnings per share 15.00%-0.1730.77%-0.1811.11%-0.24-25.68%-0.93-566.67%-0.228.57%-0.2-73.33%-0.263.57%-0.2759.78%-0.7491.30%-0.03
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+4.34%
MicroStrategy
MSTR
+4.20%
MARA Holdings
MARA
+0.66%
Apple
AAPL
+0.07%
Microsoft
MSFT
-0.51%

Unlock the Full List